4.4 Article

Liposomal delivery of ferrous chlorophyllin: A novel third generation photosensitizer for in vitro PDT of melanoma

Journal

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY
Volume 18, Issue -, Pages 162-170

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.pdpdt.2017.01.186

Keywords

Malignant melanoma; PTU inhibitor; Liposomal delivery; Fe-Chlorophyllin & PDT

Categories

Funding

  1. DAAD [ga43213]

Ask authors/readers for more resources

Background: Cutaneous melanoma (CM) has substantially increased among Caucasian populations in the past few decades. This increased the number of CM deaths throughout the world. Pigmentation of melanoma reduces the efficacy of photodynamic therapy (PDT). Third generation photosensitizers (PSs) are characterized by improved targeting to the diseased tissue and reduced systemic side effects. This study is directed towards synthesis and characterization of liposomes encapsulating sodium ferrous chlorophyllin (Fe-CHL) and assessing its efficacy as a PS in PDT of melanoma. Methods: Phenylthiourea (PTU) was used as a melanin synthesis inhibitor. PDT has been applied on de pigmented melanoma cells using liposomes-encapsulated Fe-CHL. Cell death mechanisms after PDT were evaluated. Results: Treatment of melanoma cells with 200 mu M of PTU for 48 h provided 49.9% melanin inhibition without significant cytotoxicity. Transmission electron microscope (TEM) results proved an increase in the cellular uptake of liposomes by increasing incubation period from 6 to 24 h via endocytosis with preferential accumulation in the mitochondria and the nucleus. Following de-pigmentation, PDT was applied resulting in LC50 of 18.20 and 1.77 mu M after 24 and 48 h incubation with liposomes-encapsulated Fe-CHL respectively and exposure to 56.2 J/cm(2) monochromatic red laser of wavelength of 652 nm. Mechanism of cell death of Fe-CHL mediated PDT was found to be a combination of both apoptosis and necrosis. Conclusions: Liposomes could be efficiently employed as a potential sustained release delivery system in the Fe-CHL-mediated PDT of de-pigmented melanoma. (C) 2017 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Neurosciences

Role of 3-Acetyl-11-Keto-Beta-Boswellic Acid in Counteracting LPS-Induced Neuroinflammation via Modulation of miRNA-155

Aya Shoukry Sayed, Iman Emam Omar Gomaa, Michael Bader, Nesrine Salah El Dine El Sayed

MOLECULAR NEUROBIOLOGY (2018)

Article Pharmacology & Pharmacy

Dermal delivery of Fe-chlorophyllin via ultradeformable nanovesicles for photodynamic therapy in melanoma animal model

Mai Rady, Iman Gomaa, Nagia Afifi, Mahmoud Abdel-Kader

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)

Article Biochemistry & Molecular Biology

ABCG2-mediated suppression of chlorin e6 accumulation and photodynamic therapy efficiency in glioblastoma cell lines can be reversed by KO143

Sara A. Abdel Gaber, Patricia Mueller, Wolfgang Zimmermann, Dirk Huettenberger, Rainer Wittig, Mahmoud H. Abdel Kader, Herbert Stepp

JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2018)

Article Oncology

Targeted photodynamic-induced singlet oxygen production by peptide-conjugated biodegradable nanoparticles for treatment of skin melanoma

Aya Ahmed Sebak, Iman Emam Omar Gomaa, Aliaa Nabil ElMeshad, Mahmoud Hashem AbdelKader

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2018)

Article Pharmacology & Pharmacy

Ethosomes and lipid-coated chitosan nanocarriers for skin delivery of a chlorophyll derivative: A potential treatment of squamous cell carcinoma by photodynamic therapy

Soad Nasr, Mai Rady, Iman Gomaa, Tatiana Syrovets, Thomas Simmet, Walid Fayad, Mahmoud Abdel-Kader

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)

Article Pharmacology & Pharmacy

A Naturally Derived Carrier for Photodynamic Treatment of Squamous Cell Carcinoma: In Vitro and In Vivo Models

Soad Nasr, Mai Rady, Aya Sebak, Iman Gomaa, Walid Fayad, Menna El Gaafary, Mahmoud Abdel-Kader, Tatiana Syrovets, Thomas Simmet

PHARMACEUTICS (2020)

Review Biochemistry & Molecular Biology

From Passive Targeting to Personalized Nanomedicine: Multidimensional Insights on Nanoparticles' Interaction with the Tumor Microenvironment

Aya A. Sebak, Basma M. El-Shenawy, Sara El-Safy, Mohamed El-Shazly

Summary: Nanomedicine is revolutionizing cancer treatment with unprecedented outcomes, but the heterogeneous nature of the EPR effect poses challenges. Active targeting strategies have shown limited success in enhancing therapeutic outcomes, prompting exploration of TME reengineering and the use of companion diagnostics to improve NP interactions with biological macromolecules.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2021)

Article Nanoscience & Nanotechnology

Green Synthesized Honokiol Transfersomes Relieve the Immunosuppressive and Stem-Like Cell Characteristics of the Aggressive B16F10 Melanoma

Yasmeen Ezzeldeen, Shady Swidan, Aliaa ElMeshad, Aya Sebak

Summary: This study aimed to fabricate HK transfersomes for topical treatment of melanoma, which showed potential to alleviate the immunosuppressive characteristics of the tumor and reduce the expression of stem-like cell markers. The optimized formula exhibited a mean size of 190 nm and highly negative surface charge, with promising results both in vitro and in combination with other drugs.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)

Article Engineering, Biomedical

Drugless nanoparticles tune-up an array of intertwined pathways contributing to immune checkpoint signaling and metabolic reprogramming in triple-negative breast cancer

Asmaa Ramzy, Sara ElSafy, Hisham A. Elshoky, Aya Soliman, Rana Youness, Samar Mansour, Aya Sebak

Summary: This study investigated the role of hybrid nanoparticles on the immunosuppressive characteristics of triple-negative breast cancer (TNBC) cells. The results showed that hybrid nanoparticles could convert the immunosuppressive microenvironment of TNBC to an immune-active microenvironment by reducing PD-L1 expression and reversing the Warburg effect.

BIOMEDICAL MATERIALS (2023)

Article Instruments & Instrumentation

Multitarget, multiagent PLGA nanoparticles for simultaneous tumor eradication and TME remodeling in a melanoma mouse model

Asmaa Ramzy, Aya H. Soliman, Sally I. Hassanein, Aya A. Sebak

Summary: This study aimed to design a nanoparticulate system that can accumulate in the tumor and spleen to induce local and systemic immune responses and remodel the immunosuppressive tumor microenvironment. Drug-loaded PLGA nanoparticles were used to eradicate cancer cells, silence tumor-associated fibroblasts, and re-educate tumor-associated macrophages. The nanoparticles exhibited long blood circulation time and preferentially localized in the tumor and spleen. The findings suggest the potential of remodeling the tumor microenvironment for successful chemoimmunotherapy, while also highlighting the importance of careful use of combination therapies and dose-reduction strategies.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2023)

Article Nanoscience & Nanotechnology

Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting - Part II: In vitro and in vivo Kinetics Study

Aya Ahmed Sebak, Iman Emam Omar Gomaa, Aliaa Nabil ElMeshad, Mahmoud Hussien Farag, Ulrike Breitinger, Hans-Georg Breitinger, Mahmoud Hashem AbdelKader

INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)

Article Nanoscience & Nanotechnology

Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting - Part I: In vitro Release and Intracellular Uptake Perspective

Aya Ahmed Sebak, Iman Emam Omar Gomaa, Aliaa Nabil ElMeshad, Mahmoud Hussien Farag, Ulrike Breitinger, Hans-Georg Breitinger, Mahmoud Hashem AbdelKader

INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)

No Data Available